3 news items
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies
VIR
13 May 24
("Brii Bio", stock code: 2137.HK) is a biotechnology company developing therapies to address major public health challenges where
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
ANTX
VBIV
VIR
22 Mar 24
.Postpartum Depression (PPD) and Major Depressive Disorder
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
VIR
22 Feb 24
. "Our financial strength allows us to fund multiple clinical programs through major inflection points while enabling the flexibility to invest
- Prev
- 1
- Next